Novartis AG (NVS)

Novartis AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	208,248	207,544	196,590	195,678	216,120	218,845
Market Cap Growth	1.39%	5.57%	0.47%	-9.46%	-1.25%	10.05%
Enterprise Value	225,838	219,555	205,624	198,442	242,606	236,732
PE Ratio	24.20	13.98	28.27	8.15	26.77	18.65
PS Ratio	4.17	4.45	4.52	4.45	4.33	4.50
PB Ratio	5.25	4.45	3.31	2.89	3.82	3.95
P/FCF Ratio	16.12	15.22	14.59	13.76	17.34	16.70
P/OCF Ratio	15.13	14.35	13.81	12.98	15.83	16.06
EV/Sales Ratio	4.52	4.71	4.73	4.51	4.86	4.86
EV/EBITDA Ratio	-	8.25	10.54	9.92	11.76	10.07
EV/EBIT Ratio	13.44	13.51	23.15	7.51	22.57	16.47
EV/FCF Ratio	17.48	16.10	15.26	13.96	19.47	18.07
Debt / Equity Ratio	0.69	0.57	0.47	0.46	0.67	0.53
Debt / EBITDA Ratio	-	0.99	1.43	1.55	1.84	1.25
Debt / FCF Ratio	2.11	1.94	2.07	2.19	3.05	2.24
Quick Ratio	0.60	0.82	0.94	1.20	0.60	0.70
Current Ratio	0.90	1.16	1.29	1.51	0.90	1.04
Asset Turnover	0.48	0.43	0.36	0.35	0.40	0.40
Interest Coverage	19.00	19.01	11.10	33.59	12.37	16.91
Return on Equity (ROE)	34.60%	31.50%	11.40%	42.00%	15.00%	22.70%
Return on Assets (ROA)	14.60%	13.60%	5.70%	19.30%	6.40%	9.60%
Return on Capital (ROIC)	15.22%	12.88%	7.83%	9.54%	8.76%	9.29%
Earnings Yield	7.32%	7.16%	3.54%	12.28%	3.73%	5.36%
FCF Yield	6.21%	6.57%	6.86%	7.26%	5.77%	5.99%
Dividend Yield	3.55%	3.40%	3.70%	3.90%	3.20%	2.00%
Payout Ratio	51.18%	48.50%	105.20%	31.50%	85.70%	36.40%
Buyback Yield / Dilution	3.02%	3.95%	4.57%	1.87%	0.99%	1.07%
Total Shareholder Return	6.57%	7.35%	8.27%	5.77%	4.19%	3.07%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).